Maxcyte, Inc.
MXCT- Exchange
- Nasdaq
- Industry
- Services-Commercial Physical & Biological Research
- SEC CIK
- 0001287098
No open-market purchases or sales by Maxcyte, Inc. insiders were filed in the last 90 days; 122 institutions reported holding it in 13F filings for Q2 2026, worth $78.0M in total; no superinvestor holds it.
13F holders, Q3 2024
Institutional positions in Maxcyte, Inc. as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 120
- +7 vs. Q2 2024
- Shares held
- 68.7M
- +8.54M (+14.2%) vs. Q2 2024
- Total value
- $267.4M
- +$31.3M (+13.3%) vs. Q2 2024
- New holders
- 13
- 50 more added
- Sold out
- 6
- 30 more reduced
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting MXCT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 122 | $78.0M |
| Q1 2026 | 132 | $46.2M |
| Q4 2025 | 112 | $98.0M |
| Q3 2025 | 112 | $110.8M |
| Q2 2025 | 120 | $155.5M |
| Q1 2025 | 115 | $193.8M |
| Q4 2024 | 119 | $301.9M |
| Q3 2024 | 120 | $267.4M |
| Q2 2024 | 114 | $268.0M |
| Q1 2024 | 124 | $280.8M |
| Q4 2023 | 121 | $316.1M |
| Q3 2023 | 120 | $200.8M |
| Q2 2023 | 116 | $303.3M |
| Q1 2023 | 115 | $327.9M |
| Q4 2022 | 105 | $377.7M |
| Q3 2022 | 109 | $453.8M |
| Q2 2022 | 104 | $322.7M |
| Q1 2022 | 99 | $479.8M |
| Q4 2021 | 104 | $683.6M |
| Q3 2021 | 81 | $665.4M |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2024
Shares, value and share of portfolio for each institution holding Maxcyte, Inc.; share changes are against Q2 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Mirae Asset Global Investments Co., Ltd. | 3,801 | $14.7K | 0.00% | +680+21.8% | Added |
| Tower Research Capital LLC (TRC) | 3,391 | $13.2K | 0.00% | −9,686−74.1% | Reduced |
| Amalgamated Bank | 3,303 | $13.0K | 0.00% | 00.0% | Unchanged |
| Simplex Trading, LLC | 3,499 | $13.0K | 0.00% | +1,873+115.2% | Added |
| Capital Analysts, LLC | 1,266 | $5.00K | 0.00% | 00.0% | Unchanged |
| Ridgewood Investments LLC | 1,000 | $3.89K | 0.00% | 00.0% | Unchanged |
| Quadrant Capital Group LLC | 516 | $2.01K | 0.00% | 00.0% | Unchanged |
| Sterling Capital Management LLC | 367 | $1.43K | 0.00% | +367 | New |
| Optiver Holding B.V. | 323 | $1.26K | 0.00% | −464−59.0% | Reduced |
| Daiwa Securities Group Inc. | 293 | $1.00K | 0.00% | 00.0% | Unchanged |
| Bessemer Group Inc | 300 | $1.00K | 0.00% | +300 | New |
| Lindbrook Capital, LLC | 237 | $922 | 0.00% | +121+104.3% | Added |
| Farther Finance Advisors, LLC | 217 | $844 | 0.00% | 00.0% | Unchanged |
| Smartleaf Asset Management LLC | 172 | $665 | 0.00% | +172 | New |
| Kayne Anderson Rudnick Investment Management LLC | 95 | $370 | 0.00% | 00.0% | Unchanged |
| Rothschild Investment LLC | 30 | $117 | 0.00% | 00.0% | Unchanged |
| Capital Performance Advisors LLP | 12 | $47 | 0.00% | +12 | New |
| CWM, LLC | 83 | $0 | 0.00% | +12+16.9% | Added |
| Covestor Ltd | 1 | $0 | 0.00% | −1−50.0% | Reduced |
| Bank of Montreal | 935 | – | – | 00.0% | Unchanged |
| Blue Water Life Science Advisors, LLC | 0 | $0 | 0.00% | −603,937−100.0% | Sold out |
| Massachusetts Financial Services Co | 0 | $0 | 0.00% | −499,635−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −23,406−100.0% | Sold out |
| Grandeur Peak Global Advisors, LLC | 0 | $0 | 0.00% | −16,588−100.0% | Sold out |
| Principal Financial Group Inc | 0 | $0 | 0.00% | −14,724−100.0% | Sold out |
| Advisor Group Holdings, Inc. | 0 | $0 | 0.00% | −125−100.0% | Sold out |
| BlackRock Inc. | – | – | – | – | Not filed |